AnalystsDavid DaiDavid Dai's Stock Forecasts
AnalystsDavid Dai
Sectors:
Industries:
Analyst Ranking
Bottom 3%
#4803 out of 4937 analysts
Average Return
-27.23%
Win Rate
18%4 out of 22
Risk vs Reward
Poor
Good
David Dai's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Jdcom IncJD | +122.61% | $38.35 | $85.37 | 2020-03-17 - 2021-03-17 | Buy |
Summit Therapeutics IncSMMT | +17.92% | $21.20 | $25.00 | 2025-07-01 - 2025-07-11 | Strong Buy |
Nuvalent IncNUVL | +5.09% | $77.01 | $80.93 | 2025-03-14 - 2025-07-11 | Strong Buy |
Merus NvMRUS | +4.21% | $52.30 | $54.50 | 2024-10-24 - 2025-07-11 | Strong Buy |
David Dai Analyst Color
Get additional color on David Dai's coverage of popular stocks
David Dai's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Nurix Therapeutics IncNRIX | 2 | Strong Buy | $26.00 | +109.00% | Maintains | 3 days ago |
Summit Therapeutics IncSMMT | 1 | Strong Buy | $30.00 | +20.00% | Initiates Coverage On | 12 days ago |
Blueprint Medicines CorpBPMC | 2 | Hold | $129.00 | -0.23% | Maintains | a month ago |
Iovance Biotherapeutics IncIOVA | 2 | Hold | $2.00 | +6.95% | Downgrades | 2 months ago |
Cullinan Therapeutics IncCGEM | 2 | Strong Buy | $24.00 | +211.69% | Maintains | 2 months ago |
Nuvalent IncNUVL | 2 | Strong Buy | $100.00 | +23.56% | Upgrades | 4 months ago |
Kura Oncology IncKURA | 2 | Strong Buy | $14.00 | +122.93% | Maintains | 4 months ago |
Immunocore Holdings PLCIMCR | 1 | Strong Sell | $24.00 | -31.47% | Initiates Coverage On | 9 months ago |
Perspective Therapeutics IncCATX | 1 | Strong Buy | $20.00 | +402.51% | Initiates Coverage On | 9 months ago |
Merus NvMRUS | 1 | Strong Buy | $72.00 | +32.11% | Initiates Coverage On | 9 months ago |
Janux Therapeutics IncJANX | 1 | Strong Buy | $69.00 | +174.35% | Initiates Coverage On | 9 months ago |
Ideaya Biosciences IncIDYA | 1 | Strong Buy | $50.00 | +122.42% | Initiates Coverage On | 9 months ago |
Cg Oncology IncCGON | 1 | Strong Buy | $60.00 | +124.55% | Initiates Coverage On | 9 months ago |
Syndax Pharmaceuticals IncSNDX | 1 | Strong Buy | $37.00 | +285.82% | Initiates Coverage On | 9 months ago |
Adicet Bio IncACET | 1 | Buy | $28.00 | N/A | Initiates Coverage On | 3 years ago |
Jounce Therapeutics IncJNCE | 1 | Buy | $17.00 | N/A | Initiates Coverage On | 3 years ago |
Inhibrx IncINBX1 | 1 | Buy | $40.00 | N/A | Initiates Coverage On | 3 years ago |
Macrogenics IncMGNX | 1 | Buy | $40.00 | N/A | Initiates Coverage On | 3 years ago |
Nkarta IncNKTX | 1 | Buy | $50.00 | N/A | Initiates Coverage On | 4 years ago |
Jdcom IncJD | 1 | Buy | $52.00 | N/A | Upgrades | 5 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.